Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-12 Sale | 2024-12-16 8:00 pm | Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director | 10,500 | $124.84 | $1,310,820 | 22,840 (Direct) | View |
| 2024-12-05 Sale | 2024-12-06 8:00 pm | Sarepta Therapeutics Inc. | SRPT | Boor Kathryn Jean Director | 1,636 | $125.55 | $205,400 | 5,880 (Direct) | View |
| 2024-08-30 Sale | 2024-09-03 8:00 pm | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 5,985 | $137.36 | $822,100 | 33,946 (Direct) | View |
| 2024-08-16 Purchase | 2024-08-20 08:00 am | Sarepta Therapeutics Inc. | SRPT | Chambers Michael Andrew Director | 37,038 | $133.8 | $4,955,728 | 292,311 (Indirect Direct) | View |
| 2024-06-25 Sale | 2024-06-25 8:00 pm | Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward EVP, General Counsel | 38,957 | $161.61 | $6,296,029 | 28,879 (Direct) | View |
| 2024-06-24 Sale | 2024-06-25 8:00 pm | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 11,757 | $163.13 | $1,917,891 | 23,613 (Direct) | View |
| 2024-05-02 Sale | 2024-05-06 8:09 pm | Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer | 3,635 | $140 | $508,900 | 18,125 (Direct) | View |
| 2024-03-08 Sale | 2024-03-11 8:02 pm | Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director | 15,000 | $123.25 | $1,848,795 | 22,840 (Direct) | View |
| 2024-03-11 Sale | 2024-03-11 8:00 pm | Sarepta Therapeutics Inc. | SRPT | Boor Kathryn Jean Director | 761 | $122.93 | $93,550 | 7,516 (Direct) | View |
| 2024-03-05 Sale | 2024-03-06 8:00 pm | Sarepta Therapeutics Inc. | SRPT | Mayo Stephen Director | 3,135 | $122.96 | $385,480 | 6,621 (Direct) | View |
| 2024-03-01 Sale | 2024-03-05 8:00 pm | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 2,000 | $128.84 | $257,676 | 39,222 (Direct) | View |
| 2024-03-01 Sale | 2024-03-05 8:00 pm | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 1,200 | $128.3 | $153,960 | 51,614 (Direct) | View |
| 2024-03-01 Sale | 2024-03-05 8:00 pm | Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward EVP, General Counsel | 2,000 | $125.34 | $250,680 | 44,327 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-12 Exercise | 2024-12-16 8:00 pm | 2017-02-28 2026-02-28 | Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director | 10,500 | $0 | 22,840 (Direct) | View |
| 2024-12-12 Exercise | 2024-12-16 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director | 10,500 | $13.71 | 22,840 (Direct) | View |
| 2024-11-26 Option Award | 2024-11-29 8:15 pm | 2025-11-26 2034-11-26 | Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel | 6,000 | $0 | 17,817 (Direct) | View |
Ownership | 2024-11-29 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel | 0 | $0 | 39,916 (Direct) | View |
| 2024-11-18 Tax Withholding | 2024-11-20 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 4,558 | $102.89 | 67,630 (Direct) | View |
| 2024-09-12 Option Award | 2024-09-16 8:05 pm | 2025-09-12 2034-09-12 | Sarepta Therapeutics Inc. | SRPT | Connelly Deirdre P Director | 9,284 | $0 | 9,284 (Direct) | View |
| 2024-09-04 Gift | 2024-09-05 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director | 746 | $0 | 201,093 (Direct) | View |
| 2024-07-03 Exercise | 2024-07-08 8:00 pm | 2016-02-27 2025-02-27 | Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director | 15,000 | $0 | 201,839 (Direct) | View |
| 2024-07-03 Exercise | 2024-07-08 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director | 15,000 | $13.9 | 201,839 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-25 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward EVP, General Counsel | 11,750 | $0 | 28,879 (Direct) | View |
| 2024-06-21 Exercise | 2024-06-25 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward EVP, General Counsel | 29,750 | $0 | 28,879 (Direct) | View |
| 2024-06-25 Exercise | 2024-06-25 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward EVP, General Counsel | 23,500 | $62.77 | 28,879 (Direct) | View |
| 2024-06-24 Tax Withholding | 2024-06-25 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward EVP, General Counsel | 2,352 | $164.64 | 28,879 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-25 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 11,750 | $0 | 83,891 (Direct) | View |
| 2024-06-21 Exercise | 2024-06-25 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 6,250 | $0 | 83,891 (Direct) | View |
| 2024-06-24 Tax Withholding | 2024-06-25 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 2,182 | $164.64 | 83,891 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-25 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer | 11,750 | $0 | 33,773 (Direct) | View |
| 2024-06-21 Exercise | 2024-06-25 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer | 6,250 | $0 | 33,773 (Direct) | View |
| 2024-06-24 Tax Withholding | 2024-06-25 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer | 2,352 | $164.64 | 33,773 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-25 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 11,750 | $0 | 51,681 (Direct) | View |
| 2024-06-21 Exercise | 2024-06-25 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 6,250 | $0 | 51,681 (Direct) | View |
| 2024-06-24 Tax Withholding | 2024-06-25 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 2,483 | $164.64 | 51,681 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-25 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 6,250 | $0 | 23,613 (Direct) | View |
| 2024-06-21 Exercise | 2024-06-25 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 6,250 | $0 | 23,613 (Direct) | View |
| 2024-06-24 Tax Withholding | 2024-06-25 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 2,352 | $164.64 | 23,613 (Direct) | View |
Ownership | 2024-05-06 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer | 0 | $0 | 225,778 (Direct) | View |
| 2024-03-08 Exercise | 2024-03-11 8:02 pm | 2016-02-27 2035-02-27 | Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director | 15,000 | $0 | 22,840 (Direct) | View |
| 2024-03-08 Exercise | 2024-03-11 8:02 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director | 15,000 | $13.9 | 22,840 (Direct) | View |
| 2024-03-08 Tax Withholding | 2024-03-11 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 472 | $123.14 | 25,222 (Direct) | View |
| 2024-03-07 Tax Withholding | 2024-03-11 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 506 | $120.49 | 25,222 (Direct) | View |
| 2024-03-08 Tax Withholding | 2024-03-11 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 909 | $123.14 | 68,073 (Direct) | View |
| 2024-03-07 Tax Withholding | 2024-03-11 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 512 | $120.49 | 68,073 (Direct) | View |
| 2024-03-08 Tax Withholding | 2024-03-11 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward EVP, General Counsel | 899 | $123.14 | 28,688 (Direct) | View |
| 2024-03-07 Tax Withholding | 2024-03-11 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward EVP, General Counsel | 506 | $120.49 | 28,688 (Direct) | View |
| 2024-03-08 Tax Withholding | 2024-03-11 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 1,035 | $123.14 | 36,164 (Direct) | View |
| 2024-03-07 Tax Withholding | 2024-03-11 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 526 | $120.49 | 36,164 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-06 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 1,389 | $125.32 | 37,725 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-06 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward EVP, General Counsel | 1,734 | $125.32 | 30,093 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-06 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 522 | $125.32 | 26,200 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-06 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 1,728 | $125.32 | 69,494 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:00 pm | 2025-03-01 2034-03-01 | Sarepta Therapeutics Inc. | SRPT | Nicaise Claude Director | 5,525 | $0 | 21,853 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:00 pm | 2025-03-01 2034-03-01 | Sarepta Therapeutics Inc. | SRPT | Mayo Stephen Director | 5,525 | $0 | 13,435 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director | 1,846 | $0 | 26,519 (Direct) | View |
| 2024-03-01 Exercise | 2024-03-05 8:00 pm | 2025-03-01 2034-03-01 | Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director | 3,679 | $0 | 26,519 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:00 pm | 2025-03-01 2034-03-01 | Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director | 5,525 | $0 | 190,518 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:00 pm | 2025-03-01 2034-03-01 | Sarepta Therapeutics Inc. | SRPT | Chambers Michael Andrew Director | 5,525 | $0 | 258,952 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:00 pm | 2025-03-01 2034-03-01 | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 18,500 | $0 | 39,222 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 365 | $126.19 | 39,222 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:00 pm | 2025-03-01 2034-03-01 | Sarepta Therapeutics Inc. | SRPT | Boor Kathryn Jean Director | 5,525 | $0 | 11,956 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:00 pm | 2025-03-01 2034-03-01 | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 18,500 | $0 | 51,614 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 365 | $126.19 | 51,614 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:00 pm | 2025-03-01 2034-03-01 | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 5,525 | $0 | 3,185,367 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:00 pm | 2025-03-01 2034-03-01 | Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward EVP, General Counsel | 18,500 | $0 | 44,327 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward EVP, General Counsel | 269 | $126.19 | 44,327 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:00 pm | 2025-03-01 2034-03-01 | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 18,500 | $0 | 83,722 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 778 | $126.19 | 83,722 (Direct) | View |